AXON (AXON) Form 4: COO/CFO Bagley reports 870-share sale

Rhea-AI Filing Summary

Brittany Bagley, identified as AXON's COO & CFO, reported a sale of 870 shares of AXON common stock on 09/15/2025 at a price of $773.247 per share. After the transaction she beneficially owned 113,022 shares, held directly. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Transparent disclosure of officer transaction under Section 16
• Post-transaction ownership retained at 113,022 shares, indicating substantial continued stake

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sale of 870 shares by AXON's COO/CFO is small relative to total holdings and is a routine disclosure.

The filing discloses a single non-derivative sale of 870 shares at $773.247 each, leaving 113,022 shares beneficially owned directly. As reported, this is a routine Section 16 disclosure showing an officer reduced a modest portion of holdings. There is no disclosure of derivative transactions, agreements, or unusual encumbrances. The signature was executed by an attorney-in-fact, which is a common administrative detail.

Corporate Governance Expert

TL;DR: This Form 4 documents a routine, small-scale disposition by a named officer and raises no immediate governance red flags.

The report identifies the reporting person as both COO and CFO and records a single sale of 870 shares on 09/15/2025 with post-transaction direct ownership of 113,022 shares. The absence of amendments, derivative transactions, or multiple reporting persons suggests a straightforward disclosure. The filing includes an attorney-in-fact signature, indicating the report was prepared or filed by an authorized representative.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bagley Brittany

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO & CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		S		870	D	$773.247	113,022	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Brittany Bagley by Isaiah Fields, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did AXON insider Brittany Bagley report on Form 4?

The Form 4 reports a sale of 870 shares of AXON common stock on 09/15/2025 at a price of $773.247 per share.

What is Brittany Bagley's role at AXON as listed on the Form 4?

The Form 4 lists Brittany Bagley as an Officer with titles COO & CFO.

How many AXON shares did Brittany Bagley own after the reported transaction?

Following the sale, she beneficially owned 113,022 shares, held directly.

Was the Form 4 signed by the reporting person?

The filing shows it was signed by an attorney-in-fact (/s/ Brittany Bagley by Isaiah Fields, Attorney-in-Fact) on 09/15/2025.

Are there any derivative transactions reported for Brittany Bagley on this Form 4?

No. The Form 4 includes no entries in Table II for derivative securities.